Browsing Tag
Strides Pharma Science
16 posts
Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders
Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by…
April 9, 2024
Strides Pharma Science receives FDA approval for Pregabalin capsules
Strides Pharma Science Limited (Strides) has achieved a significant milestone in the pharmaceutical industry with the United States…
January 25, 2024
Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules
Strides Pharma Science Limited (“Strides”) has joined forces with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) to introduce Icosapent…
December 2, 2023
Strides Pharma subsidiary receives FDA approval for bowel prep solution
Strides Pharma Science Limited, through its subsidiary Strides Pharma Global Pte. Limited, Singapore, has recently achieved a significant…
November 23, 2023
Strides Pharma subsidiary gains FDA approval for EET tablets
Strides Pharma Science Limited has announced a significant achievement, with its wholly-owned subsidiary, Strides Pharma Global Pte. Limited…
October 5, 2023
Strides Pharma’s HIV generic drug gets tentative FDA approval
Strides Pharma Science Limited (Strides) announced that its Singapore-based stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited,…
September 14, 2023
Strides Pharma wins FDA approval for kidney drug Sevelamer Carbonate
In a major coup for Strides Pharma Science Limited, the company’s stepdown wholly-owned subsidiary, Strides Pharma Global Pte.…
September 10, 2023
Strides Pharma gets FDA nod for Mycophenolate Mofetil, targets $145m market
Strides Pharma Science Limited has announced a significant win as its Singapore-based wholly owned subsidiary, Strides Pharma Global…
August 30, 2023
Strides Pharma Science’s CDMO unit gets FDA EIR for Bengaluru facility
Strides Pharma Science said that its biologics arm Stelis Biopharma has secured an establishment inspection report (EIR) from…
January 18, 2023
Strides Pharma gets FDA approval for Potassium Chloride Oral Solution generic
Strides Pharma Science has secured approval for Potassium Chloride Oral Solution USP, 40 mEq/15mL (20%) from the US…
November 20, 2022